Neuland Laboratories Hits New 52-Week High of Rs. 19,748.4

Neuland Laboratories has reached a significant milestone by hitting a new 52-week high of Rs. 19,748.4 on November 10, 2025. This achievement marks a notable performance for the small-cap pharmaceutical and biotechnology company, which has outperformed its sector by 1.64% today. The stock has shown consistent upward momentum, gaining 3.98% over the last two days and opening with a substantial gain of 6.11%. Intraday trading saw the stock peak at Rs. 19,748.4, reflecting a 10.81% increase. Neuland Laboratories is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong market position. In the past year, Neuland Laboratories has delivered a robust return of 31.24%, significantly outperforming the Sensex, which has risen by only 5.21% during the same period. The company has also reported impressive financial metrics, including a record operating cash flow of Rs. 317.38 crore and net sales of Rs. 514.27 crore in the latest quarter. With high institutional holdings at 34.55%, Neuland Laboratories continues to demonstrate its capacity for growth and stability in the competitive pharmaceutical landscape.